US-India Healthcare Summit: New Business Models Needed To Reach the World's Poor
This article was originally published in The Pink Sheet Daily
Executive Summary
The "bottom of the pyramid" represents a huge opportunity for Western companies, but they need to overcome hurdles to maximize the potential - and to fend off competitors emerging from around the world.
You may also be interested in...
Pfizer Delves Deeper In Generics Partnership With Strides Arcolab
NEW DELHI - Pfizer has further expanded its generic drug portfolio by signing two more license and supply agreements with Strides Arcolab, just four months after Pfizer partnered with the Bangalore-based drug manufacturer to bring generic injectable and oral drugs to the U.S. market
Abbott Ups Emerging Markets Ante With Zydus Deal, Established Products Unit
The acquisition of Solvay's pharmaceutical unit, completed in February, gave Abbott a substantial branded generics business and strengthened its international presence. Now the company is looking to build on those assets with an enhanced emerging market strategy
Pre-Competitive Collaboration Would Help Pharmaceutical Productivity Crisis - If Lawyers Could Get Out Of The Way
CAMBRIDGE, Mass. - Greater R&D collaboration was the theme of the day at the star-studded U.S.-India Chamber of Commerce biopharma and healthcare summit